Advertisement

Topics

The evolution of switching and substitution of biosimilars in Europe

04:39 EDT 20 Oct 2017 | Generics and Biosimilars Initiative

Switching patients from originator biologicals is often an emotive subject. However, despite reservations by prescribers and payers alike the tide may be finally turning, with Scandinavian countries leading the way [1].

Original Article: The evolution of switching and substitution of biosimilars in Europe

NEXT ARTICLE

More From BioPortfolio on "The evolution of switching and substitution of biosimilars in Europe"

Quick Search
Advertisement